SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Glycotex Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101